The COVID-19 and M.pneumoniae IgG/IgM Combo Rapid Test is for the qualitative detection of IgG and IgM antibodies to SARS-COV-2 and Mycoplasma pneumoniae in human whole blood, serum or plasma specimen. It is for professional use only and is intended to be used as an aid in the diagnosis of patients with suspected SARS-CoV-2/M.pneumoniae infection in conjunction with clinical presentation and the results of other laboratory tests.
Product Features
Fast results
Easy visual interpretation
Simple operation, no equipment required
High accuracy
PRODUCT SPECIFICATION
- PrincipleChromatographic Immunoassay
- FormatCassette
- SpecimenWB/S/P
- CertificateCE
- Reading Time10 minutes
- Pack25 T
-
Storage Temperature
2-30°C
- Shelf Life2 Years
- Sensitivity100%(COVID-19 IgG) / 85.0%(COVID-19 IgM) / 92.2%(Mycoplasma pneumoniae IgG) / 91.5%(Mycoplasma pneumoniae IgM)
- Specificity98.0%(COVID-19 IgG) / 96.0%(COVID-19 IgM) / 94.6%(Mycoplasma pneumoniae IgG) / 94.8%(Mycoplasma pneumoniae IgM)
- Accuracy98.6%(COVID-19 IgG) / 92.9%(COVID-19 IgM) / 93.7%(Mycoplasma pneumoniae IgG) / 93.7%(Mycoplasma pneumoniae IgM)
Ordering Information
- Cat. No.INMC-425
- ProductCOVID-19 and M.pneumoniae IgG/IgM Combo Rapid Test
- SpecimenWB/S/P
- Pack25 T
- Cut-OffSee Insert
- Cat. No.INMCG-425
- ProductCOVID-19 and M.pneumoniae IgG Combo Rapid Test
- SpecimenWB/S/P
- Pack25 T
- Cut-OffSee Insert
